Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03500211 · ClinicalTrials.gov registry record · Phase 4
Post-Op Lidocaine Patch
A Phase 4 study of Pain, Postoperative, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT03500211 is a Phase 4 study of Pain, Postoperative that has completed, run by Oregon Health and Science University. The registered enrollment target is 50 participants, below the 272-participant average among 108 other Pain, Postoperative trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03500211, a Phase 4 study of Pain, Postoperative, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Randomized control trial evaluating use of lidocaine vs placebo patch for post-operative cesarean incision pain.
Conditions Studied
Interventions
- DRUG Lidoderm 5 % Topical Patch
- OTHER Sham Topical Patch
Study Locations (1)
Oregon
- Oregon Health and Science University - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2018-03-13 |
| Est. Completion | 2019-03-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03500211
The ClinicalTrials.gov registry entry for NCT03500211 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 272-participant average among 108 other Pain, Postoperative trials with a reported enrollment target (82% lower). The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pain, Postoperative appearing as the primary indexed condition, and to 2 interventions - of which Lidoderm 5 % Topical Patch is the first listed.
NCT03500211 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.
Frequently Asked Questions
What is clinical trial NCT03500211 about?
NCT03500211 is a clinical study titled "Post-Op Lidocaine Patch". Randomized control trial evaluating use of lidocaine vs placebo patch for post-operative cesarean incision pain.
What is the current status of trial NCT03500211?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2018-03-13. Estimated completion is 2019-03-01.
What conditions does trial NCT03500211 study?
This clinical trial studies the following conditions: Pain, Postoperative.
What interventions are being tested in trial NCT03500211?
The interventions under investigation include: Lidoderm 5 % Topical Patch (DRUG), Sham Topical Patch (OTHER).
Who is sponsoring clinical trial NCT03500211?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03500211 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain, Postoperative
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Management of Postoperative Discomfort in Young Children Following Dental Rehabilitation Under General Anesthesia
RECRUITING · Phase 4
-
Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery
RECRUITING · Phase 4
-
The Effect of Zolpidem on Outcomes Following Lumbar Spine Fusion
RECRUITING · Phase 4
-
Comparing Analgesic Regimen Effectiveness and Safety for Surgery (CARES) Trial
RECRUITING · Phase 4
-
IPACK on Early Pain Scores After ACL Reconstruction
RECRUITING · Phase 4
-
Liposomal Bupivacaine Versus Lidocaine for Skin Graft Donor Site Pain
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.